Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Mutation Research
|
August 30, 2001
The genotoxic risk of hospital, pharmacy and medical personnel occupationally exposed to cytostatic drugs--evaluation by the micronucleus assay
H Hessel, K Radon, A Pethran, et al.
The American Review of Respiratory Disease
|
August 1, 1993
Activation of blood neutrophils in acute episodes of farmer's lung
C Vogelmeier, F Krombach, S Münzing, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 1, 1996
Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung
J Behr, C Vogelmeier, T Beinert, et al.
Thorax
|
July 1, 1993
Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis
J Behr, B C Adelmann-Grill, F Krombach, et al.
International Archives of Occupational and Environmental Health
|
January 1, 1997
Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies
A S Ensslin, R Huber, A Pethran, et al.
Respiration; International Review of Thoracic Diseases
|
January 1, 1982
Extrinsic allergic alveolitis combined with celiac disease in childhood
G König, E Albert, M Dewair, et al.
Chest
|
March 1, 1984
Lung involvement in scleroderma
G König, C Luderschmidt, C Hammer, et al.
Lung
|
January 1, 1988
Humidifier lung and humidifier fever
X Baur, J Behr, M Dewair, et al.
Pneumologie (Stuttgart, Germany)
|
April 1, 1995
[Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts]
J Behr, B C Adelmann-Grill, R Hein, et al.
Respiration; International Review of Thoracic Diseases
|
January 1, 1995
Pathogenetic and clinical significance of fibroblast activation in scleroderma lung disease
J Behr, B C Adelmann-Grill, R Hein, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Mutation Research
|
August 30, 2001
The genotoxic risk of hospital, pharmacy and medical personnel occupationally exposed to cytostatic drugs--evaluation by the micronucleus assay
H Hessel, K Radon, A Pethran, et al.
The American Review of Respiratory Disease
|
August 1, 1993
Activation of blood neutrophils in acute episodes of farmer's lung
C Vogelmeier, F Krombach, S Münzing, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 1, 1996
Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung
J Behr, C Vogelmeier, T Beinert, et al.
Thorax
|
July 1, 1993
Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis
J Behr, B C Adelmann-Grill, F Krombach, et al.
International Archives of Occupational and Environmental Health
|
January 1, 1997
Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies
A S Ensslin, R Huber, A Pethran, et al.
Respiration; International Review of Thoracic Diseases
|
January 1, 1982
Extrinsic allergic alveolitis combined with celiac disease in childhood
G König, E Albert, M Dewair, et al.
Chest
|
March 1, 1984
Lung involvement in scleroderma
G König, C Luderschmidt, C Hammer, et al.
Lung
|
January 1, 1988
Humidifier lung and humidifier fever
X Baur, J Behr, M Dewair, et al.
Pneumologie (Stuttgart, Germany)
|
April 1, 1995
[Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts]
J Behr, B C Adelmann-Grill, R Hein, et al.
Respiration; International Review of Thoracic Diseases
|
January 1, 1995
Pathogenetic and clinical significance of fibroblast activation in scleroderma lung disease
J Behr, B C Adelmann-Grill, R Hein, et al.
Page
of 12